NF-κB Activation Inhibitor III aroxime Smiles: COC1=CC(=CC2=C1N(CCCCC)C=C(C2=O)C(=O)N[C@]12CC3C[C@H](C1)C[C@H](C2)C3)C1=CC=CO1

Smiles: COC1=CC(=CC2=C1N(CCCCC)C=C(C2=O)C(=O)N[C@]12CC3C[C@H](C1)C[C@H](C2)C3)C1=CC=CO1

InChi: InChI=1S/C26H24N6OS/c1-16-5-3-6-18(28-16)15-32-21-8-4-7-20(24(21)25(30-32)17-9-10-17)29-26(33)22-14-27-23-13-19(34-2)11-12-31(22)23/h3-8

InChi: InChI=1S/C31H39N5O7/c1-31(2

Thalidomide-OH is a putative hydroxylated thalidomide metabolite

exposing a new amino terminal sequence that functions as a tethered ligand to activate the receptors

NF-κB Activation Inhibitor III aroxime Smiles: COC1=CC(=CC2=C1N(CCCCC)C=C(C2=O)C(=O)N[C@]12CC3C[C@H](C1)C[C@H](C2)C3)C1=CC=CO1NF B Activation Inhibitor III is a NF B inhibitor. NF B (nuclear factor kappa light chain enhancer of activated B cells) is a protein complex controling transcription of DNA, cytokine production as well as cell survival. NF B is found in nearly all animal cell types and is involved in cellular responses to stimuli such as cytokines, stress, free radicals, heavy metals, and bacterial or viral antigens. In vitro: Previous study found that NF B